February 12, 2020
As a company located right in Wuhan and being RNA technology-centered, ABLife has initiated two projects to help our city to combat the 2019-nCov epidemic. To make the recent research progress more visible to Chinese readers, we are translating all the recently published research articles/letters and related correspondence/editorial comments into Chinese and posted it for in our website (www.ablife.cc) and official Wechat site (生命之美). This project was officially started from the last Thursday, February 6. Another project is to develop a more sensitive and reliable method for quick detection of 2019-nCov viral RNA. We are doing what we can do and should do to help our city back to normal pace. Keep it up, Wuhan!
Meanwhile, we are working very hard to keep our pace to move forward each of our customer’s project. Most of employee have started to work online in the last Monday. Although it was much less effective in the beginning, we feel that it is getting better this week. I would like to specifically mention that our laboratory work has been severely hindered due to the fact that most of our lab employee were away from Wuhan and they cannot return to the lab due to the epidemic-related restrictions. We anticipate that our success in developing the highly sensitive and reliable 2019-nCov detection method, hopefully in the coming week, will help us to bring back our lab employee very soon. Now the submission deadline for the National Science Foundation grant applications has been postponed, similar are many other official grant applications and probably the graduation dates. We hope that our serious efforts in restoring our working pace can continue the strong support of our customers’ research pace in 2020.
Thanks so much for being with ABLife, and your understanding of any delay due to the 2019-nCov epidemic in Wuhan.
Wish you and your family a healthy and prosperous 2020!